JPRN-UMIN000032277已完成未知
The differecnces between SGLT2 and DPP4 inhibitors in blood glucose management and cardiac sympathetic nerve activity - The differences between SGLT2 and DPP4 inhibitors in cardiac sympathetic nerve activity
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnancy, breast-feeding, patients who may be pregnant, and patients who want pregnancy during the study Patients who may be thought to worse blood glucose management with the protocol of this study Patients with moderate or severe renal impairment (less than eGFR45) Patients with severe hepatic impairment (Child-Pugh classification C) Patients who were judged inappropriate as subjects of this study by investigators
研究者
相似试验
已完成
不适用
Comparison of SGLT2 inhibitors versus DPP-4 inhibitors for diabetic macular edemaType 2 diabetes mellitusJPRN-UMIN000015873Yokohama City University Medical Center30
尚未招募
不适用
SGLT2 inhibitor versus DPP-4 inhibitor on left ventricular ejection fraction measured by echocardiography in diabetic patients with acute myocardial infarction and midranged ejection fraction (EMPA-MI-MREF)Diseases of the circulatory systemKCT0007622Chonnam National University Hospital600
终止
不适用
Combination of SGLT2 inhibitor and DPP-4 inhibitor as add-on therapy in subjects with type 2 diabetes inadequately controlled on insulin combined with metformin + DPP-4 inhibitor or metformin + SGLT2 inhibitor or metformin : open-label, multicenter trialKCT0004959Korea University Anam Hospital102
已完成
不适用
Effects of DPP4 inhibitor, sitagliptin or Sulfonylurea on intrahepatic adipose mass and lipid metabolism in patients with type 2 diabetes accompanied by fatty liver : a prospective randomized, open-label trialType 2 diabetesJPRN-UMIN000013356St.Marianna University School of Medicine60
已完成
Unknown
Effects of combined SGLT2 inhibitor and DPP-4 inhibitor therapy on advanced glycation end productsType 2 diabetesJPRN-UMIN000049408Akishima Clinic35